Laurence Marton is Director at RenovoRx, Inc. (RNXT). They have made 1 open-market trade across 1 company since 2024, most recently 2026-05-22.
CIK 0001862192
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $10K since 2024, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| RNXT | 66,164 | $76K |
| PrivateUnlisted | 52,003 | — |
| Total | $76K |
Shares reported on the most recent Form 4, priced at the 2026-05-27 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| RNXT | BUY | 2025-04-08 | 2025-04-09 | $0.85 | $10K | +12.9% | +26.0% | +54.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.